company
Paid contract research organization that synthesized designs and measured binding.
No evidence-backed relationships are recorded.
Google DeepMind's SynthID Bio embeds a traceable mark in an AI-designed protein that a detector can find in the physical molecule, without changing how it works. The mark is meant to help DNA synthesis firms screen orders and trace which model made a sequence.
Reality
Claude agents designed 1,440 protein binders and 354 bound. The interesting part is that the prompts, provenance and every measurement went out with the number.
Reality
The saving comes off cache reads, so it lands unevenly across teams, and the model's most sensitive capability now reaches users through a credential issued by an access program, not a purchase order a budget holder can sign off alone. Both changes move the decision away from the budget holder.
Perspective Coverage
3 publishersReality
Two contract labs made and tested Claude's designs, which is genuinely new. The field baseline those results are scored against comes from the company that ran the experiment.
Reality
A one-day hackathon put agent-designed binders through Adaptyv Bio's wet-lab screen. The durable result is that the designs cleared a shared assay at all, not that any single model won.
Reality